Abstract
Background
Long-chain polyunsaturated fatty acids (LC-PUFA), particularly docosahexaenoic acid (DHA) and arachidonic acid, are, respectively, n-3 and n-6 family members and play an important role in fetal and infant growth and development. Pregnancy and lactation impose special nutritional needs for the mother-fetus situation. Since the LC-PUFA required by the fetus is supplied by preferential placental transfer of preformed LC-PUFA rather than their precursor, it has been hypothesized that additional maternal supply of LC-PUFA, especially DHA, during pregnancy may improve maternal and infant outcomes.
Aim
To summarize evidences of the effect of n-3 LC-PUFA intake during pregnancy and lactation on maternal and infant outcomes in order to offer a comprehensive view of this issue that should be useful for clinical practice.
Results
Maternal n-3 LC-PUFA supplementation may reduce risk for early preterm birth >34 weeks and seems very promising for primary allergy prevention during childhood. On the contrary, there are not sufficient data proving that the consumption of oils rich in n-3 LC-PUFA during pregnancy optimizes child’s visual and neurodevelopment and reduces the risk for preeclampsia and perinatal depression; the implications of these findings remain to be elucidated.
Conclusion
The implications of n-3 LC-PUFA supplementation on fetal development, maternal outcomes and later infant growth is worth being elucidated and is promising in its potential for a positive impact on fetal and maternal outcomes.
Similar content being viewed by others
References
Calder PC (2012) The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol Nutr Food Res 56:1073–1080
Szajewska H, Horvath A, Koletzko B (2006) Effect of n–3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Am J Clin Nutr 83:1337–1344
Mozurkewich EL (2012) Curr Opin Obstet Gynecol 24:72–77
Hanebutt FL, Demmelmair H, Schiessl B et al (2008) Long-chain polyunsaturated fatty acid (LC-PUFA) transfer across the placenta. Clin Nutr 27(5):685–693
Larqué E, Demmelmair H, Berger B et al (2003) In vivo investigation of the placental transfer of (13)C-labelled fatty acids in humans. J Lipid Res 44(1):49–55
Haggarty P, Ashton J, Joynson M et al (1999) Effect of maternal polyunsaturated fatty acid concentration on transport by the human placenta. Biol Neonate 75(6):350–359
Morse NL (2012) Benefits of docosahexaenoic acid, folic acid, vitamin D and iodine on foetal and infant brain development and function following maternal supplementation during pregnancy and lactation. Nutrients 4:799–840
Dziechciarz P, Horvath A, Szajewska H (2010) Effects of n-3 long-chain polyunsaturated fatty acid supplementation during pregnancy and/or lactation on neurodevelopment and visual function in children: a systematic review of randomized controlled trials. J Am Coll Nutr 29(5):443–454
Gould JF, Smithers GL, Makrides M (2013) The effect of maternal omega-3 (n-3) LCPUFA supplementation during pregnancy on early childhood cognitive and visual development: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 97:531–544
Larqué E, Sánchez GA, Prieto-Sánchez MT, Koletzko B (2012) Omega 3 fatty acids, gestation and pregnancy outcomes. Brit J Nutr 107:S77–S84
Luchtman DW, Song C (2013) Cognitive enhancement by omega-3 fatty acids from child-hood to old age: findings from animal and clinical studies. Neuropharmacology 64:550–565
Lo A, Sienna J, Mamak E et al (2012) The effects of maternal supplementation of polyunsaturated fatty acids on visual, neurobehavioural, and developmental outcomes of the child: a systematic review of the randomized trials. Obstet Gynecol Int. doi:10.1155/2012/591531
Judge MP, Harel O, Lammi-Keefe CJ (2007) A docosahexaenoic acid-functional food during pregnancy benefits infant visual acuity at four but not 6 months of age. Lipids 42(2):117–122
Malcolm CA, Hamilton R, McCulloch DL et al (2003) Scotopic electroretinogram in term infants born of mothers supplemented with docosahexaenoic acid during pregnancy. Invest Ophthalmol Vis Sci 44(8):3685–3691
Helland IB, Saugstad OD, Smith L et al (2001) Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 108(5):E82
Helland IB, Smith L, Saarem K et al (2003) Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics 111(16):E39–E44
Helland IB, Smith L, Blomen B et al (2008) Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children’s iq and body mass index at 7 years of age. Pediatrics 122(2):E472–E479
Judge MP, Harel O, Lammi-Keefe CJ (2007) Maternal consumption of a docosahexaenoic acid-containing functional food during pregnancy: benefit for infant performance on problem-solving but not on recognition memory tasks at age 9 months. Am J Clin Nutr 85(6):1572–1577
Dunstan JA, Simmer K, Dixon G et al (2008) Cognitive assessment of children at age 2 (1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch Dis Child 93(1):F45–F50
Szajewska H, Makrides M (2011) Is early nutrition related to short-term health and long-term outcome? Ann Nutr Metab 58:38–48
No authors listed (2009) Alternative medicine review 14(4):391–399
Olsen SF, Hansen HS, Sorensen TI et al (1993) Intake of marine fat, rich in (n–3)-polyunsaturated fatty acids, may increase birthweight by prolonging gestation. Lancet 1986(2):367–369
Olsen SF, Grandjean P, Weihe P, Videro T (1993) Frequency of seafood intake in pregnancy as a determinant of birth weight: evidence for a dose dependent relationship. J Epidemiol Community Health 47:436–440
Makrides M, Duley L, Olsen SF (2006) Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev 19(3): CD003402
Salvig JD, Lamont RF (2011) Evidence regarding an effect of marine n-3 fatty acids on preterm birth: a systematic review and meta-analysis. Acta Obstetricia et Gynecologica Scandinavica C _ 2011 Nordic Federation of Societies. Obstet Gynecol 90:825–838
Horvath A, Koletzko B, Szajewska H (2007) Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Br J Nutr 98(2):253–259
Simmer K, Patole SK, Rao SC (2011) Long-chain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev. doi:10.1002/14651858
Calder PC, Kremmyda LS, Vlachava M et al (2010) 3rd international immunonutrition workshop session 5: early programming of the immune system and the role of nutrition is there a role for fatty acids in early life programming of the immune system? Proc Nutr Soc 69:373–380
Anandan C, Nurmatov Sheikhconduct A (2009) Omega 3 and 6 oils for primary prevention of allergic disease: systematic review and meta-analysis. Allergy 64:840–848
Klemens CM, Berman DR, Mozurkewich EL (2011) The effect of perinatal omega-3 fatty acid supplementation on inflammatory markers and allergic diseases: a systematic review. BJOG 118:916–925
Kremmyda LS, Vlachava M, Noakes PS et al (2011) Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review. Clin Rev Allergy Immunol 41(1):36–66
Lauritzen L, Kjaer TMR, Fruekilde MB et al (2005) Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2-year-old children. Lipids 40:669–676
Zhou SJ, Yelland L, McPhee AJ et al (2012) Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. Am J Clin Nutr 95:1378–1384
De Vriese SR, Christophe AB, Maes M (2003) Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci 73:3181–3187
Golding J, Steer C, Emmett P et al (2009) High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish. Epidemiology 20:598–603
Jans LAW, Giltay EJ, Van der Doesdid AJW (2010) The efficacy of n-3 fatty acids DHA and EPA (fish oil) for perinatal depression. Br J Nutr 104:1577–1585
Su KP, Huang SY, Chiu TH et al (2008) Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 69:644–651
Kim YJ, Jeong DW, Lee JG et al (2012) Omega-3 index and smoking in patients with acute ST-elevation myocardial infarction taking statins: a case-control study in Korea. Lipid Health Dis 11:43
Block RC, Harris WS (2008) Determinants of blood cell omega-3 fatty acid content. Open Biomark J 1:1–6
Agostoni C, Riva E, Giovannini M et al (2008) Maternal smoking habits are associated with differences in infants’ long-chain polyunsaturated fatty acids in whole blood: a case-control study. Arch Dis Child 93:414–418
Craig WJ (2009) Health effects of vegan diets. Am J Clin Nutr 89:1627S–1633S
Sanders TAB (2009) DHA status of vegetarians. Prostaglandins Leukot Essent Fatty Acids 81:137–141
Craig WJ, Mangels AR, American Dietetic Association (2009) Position of the American dietetic association: vegetarian diets. J Am Diet Assoc 109(7):1266–1282
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
De Giuseppe, R., Roggi, C. & Cena, H. n-3 LC-PUFA supplementation: effects on infant and maternal outcomes. Eur J Nutr 53, 1147–1154 (2014). https://doi.org/10.1007/s00394-014-0660-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-014-0660-9